![1,2,4-Thiadiazole-3-asid acetic, 5-amino-a-[[2-(1,1-dimethylethoxy)-1,1-dimethyl-2-oxoethoxy]imino]-, (Z) - CAS NO.:76028-96028](/uploads/24095/1-2-4-thiadiazole-3-acetic-acid-5-amino-a-2-103aae.png)
![1,2,4-Thiadiazole-3-acetic Acid, 5-amino-a-[[2-(1,1-dimethylethoxy)-1,1-dimethyl-2-oxoethoxy]imino]-, (Z)- CAS NO.:76028-96-1 suppliers](/uploads/24095/page/1-2-4-thiadiazole-3-acetic-acid-5-amino-a-2-1ec7af.png "1,2,4-Thiadiazole-3-acetic Acid, 5-amino-a-[[2-(1,1-dimethylethoxy)-1,1-dimethyl-2-oxoethoxy]imino]-, (Z)- CAS NO.:76028-96-1 suppliers")
|
1,2,4-Thiadiazol-3-asid acetic, 5-amino-a-[[2-(1,1-dimethylethoxy)-1,1-dimethyl-2-oxoethoxy]imino]-, (Z)-
|
|
Non pwodwi:
|
1,2,4-Thiadiazol-3-asid acetic, 5-amino-a-[[2-(1,1-dimethylethoxy)-1,1-dimethyl-2-oxoethoxy]imino]-, (Z)-
|
|
Sinonim:
|
(Z)-2-[[1-(tèt-butoksikarbonil){-1-Methylethoxy]iMino]-2{{ 38}}(5-AMino-[1,2,4]tiadyazol-3-il)-asid asetik;(Z)-2-(5-aMin o-1,2,4-thiadiazol-3-yl)-2-(1-tert-butoxy-2-Methyl-1-oxopropan-2-yloxyiMino)aceticacid;1,2,4-Thiadiazole-3-aceticacid,5-amino-a-[[2-(1,1-dimethylethoxy)-1,2-ioxydioxyethoxy o]-,(Z)-;2-(5-AMino-1,2,4-thChemicalbookiadiazol-3-yl)-2-(((1-butoxy-1-oxopropan-2-yl)oxy)iMino)aceticacid;1,2,4-Thiadiazole-3-aceticacid,5-amino-a-a-1[[2)-(dimethyle1thoxy) thyl-2-oxoethoxy]imino]-,(Z)-(RelatedReference);EOS-61787;(S)-2-Benzothiazolyl;1,2,4-Thiadiazole-3-aceticacid,5-amino- -[[2-(1,1-dimethylethoxy)-1,1-dimethylethoxy]-dixoethoxy]-dixotoxy, Z)-
|
|
CAS:
|
76028-96-1
|
|
MF:
|
C12H18N4O5S
|
|
mw:
|
330.36
|
|
EINECS:
|
616-285-5
|
1,2,4-Thiadiazol-3-asid acetic, 5-amino-a-[[2-(1,1-dimethylethoxy)-1,1-dimethyl-2-oxoethoxy]imino]-, (Z)-
|
Dansite
|
1.41±0.1 g/cm3 (Prevwa)
|
|
Pwen bouyi
|
487.8±47.0 degre (Prevwa)
|
|
Apk
|
2.13±0.41 (Prevwa)
|
|
Solibilite
|
Soluble nan DMSO (ti kantite), metanol (ti kantite)
|
|
Tanperati depo.
|
2-8 degre
|
|
Fòm
|
Solid
|
|
Koulè
|
Blan a-blan
|
Itilizasyon
|
Itilizasyon
|
Kle matyè premyè pou sentèz cefozopran
Cefozopran se yon katriyèm -jenerasyon antibyotik sefalosporin ak aktivite anti-bakteri gwo-. Li gen gwo efè inhibitor sou bakteri Gram-pozitif, bakteri Gram-negatif (ki gen ladan kèk tansyon ki reziste dwòg-), epi li klinikman itilize nan tretman enfeksyon grav tankou enfeksyon nan aparèy respiratwa, enfeksyon nan sistèm urin, ak sepsis. Thioester aktif nan asid chenn side-cefozopran sibi yon reyaksyon kondansasyon ak nwayo cephalosporin (tankou 7-dérivés ACA) pou prezante yon estrikti chèn bò espesifik, kidonk konstwi estrikti chimik konplè cefozopran. Li se yon entèmedyè endispansab nan pwodiksyon endistriyèl antibyotik sa a. Baz estriktirèl pou asire aktivite anti-bakteri
Gwoup thioester aktif nan molekil li yo gen gwo reyaksyon, sa ki ka efikasman acylate gwoup amine nan nwayo cephalosporin pou fòme yon kosyon amid ki estab, finalman dote cefozopran ak yon estrikti chèn inik -. Èstrikti chèn kote-sa a se yon garanti enpòtan pou cefozopran pou egzèse efè anti-bakteri li yo ak amelyore afinite li pou bakteri penisilin-pwoteyin obligatwa (PBPs), ki afekte dirèkteman spectre anti-bakteri ak efikasite nan dwòg la. |
Baj popilè: 1,2,4-Thiadiazole-3-asid acetic, 5-amino-a-[[2-(1,1-dimethylethoxy) -1,1-dimethyl-2-oxoethoxy] imino]-, (Z) - CAS NO .: 76021, Lachin, manifaktirè, repòtaj, founisè, faktori, 96-
